Botanix News Hub
Welcome to our home for news – the latest headlines, all in one place. Click through to view a selection of our media coverage, industry news, videos and more.
Welcome to our home for news – the latest headlines, all in one place. Click through to view a selection of our media coverage, industry news, videos and more.
Botanix announces landmark descheduling of synthetic CBD by DEA
/in Latest News /by administratorUpdates on 3 Health Care Stocks – Allegra, Althea and Botanix
/in Latest News /by administratorhttps://kalkinemedia.com/au/blog/whats-latest-with-four-health-care-stocks-heramed-allegra-althea-and-botanix
Botanix Pharma – tell us, is it good or bad?
/in Latest News /by administratorBotanix announces CBD supply agreement with Purisys
/in Latest News /by administratorBotanix signs a supply agreement with Purisys
/in Featured, Latest News /by administratorBotanix Pharmaceuticals has entered into a supply agreement with Purisys. Purisys has one of the industry’s longest track records and a wide range of offerings in the cannabinoid space. It currently produces all major cannabinoids relevant to pharmaceutical and consumer products. Since 2016, Purisys has also manufactured pharmaceutical-grade cannabidiol at commercial scale utilising a patented process.
Click HERE to read the article on The Market Herald.
Pharma giants to unveil major $1 billion venture to push novel antibiotics
/in Featured, Latest News /by administratorAmid escalating concerns over antibiotic resistance, several big drug makers are creating a new $1 billion for-profit venture to acquire or invest in small antibiotic companies and their nascent products, according to two people familiar with the plans.
Click HERE to see the article on STAT.